NCT Neuro Master Match - N²M² (NOA-20)

NCT03158389 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma, Adult

Interventions

DRUG: APG101
DRUG: Alectinib
DRUG: Idasanutlin
DRUG: Atezolizumab
DRUG: Vismodegib
DRUG: Temsirolimus
DRUG: Palbociclib

Sponsor

University Hospital Heidelberg

Collaborators

[object Object]
[object Object]
[object Object]